Question 1

What is the catalog number for Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-?

Accepted Answer

The catalog number for Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is TNU0422L.

Question 2

What sizes are available for Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-?

Accepted Answer

Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- come in?

Accepted Answer

Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is available in 3 different pack sizes.

Question 4

Is Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- in stock?

Accepted Answer

Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-?

Accepted Answer

Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is manufactured by Molfinity.

Question 6

What is the estimated delivery time for Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-?

Accepted Answer

Estimated delivery time for Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo- is approximately 10 business day(s), depending on your location.

Question 7

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 8

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 9

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Pyrazinecarboxamide, 3,4-dihydro-4-[5-O-[hydroxy[[hydroxy (phosphonooxy) phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-

Product Specifications

CAS Number

Target

Related Pathways

Bioactivity

Smiles

Molecular Formula

Molecular Weight

Shipping Conditions

Storage Temperature

Available Sizes

Frequently Asked Questions

Explore Other Products

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL

E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF405S conjugate, 0.1mg/mL

CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF405S conjugate, 0.1mg/mL

CD16 (C16/1045), CF488A conjugate, 0.1mg/mL

CD50 (ICAM-3) (186-2G9), CF568 conjugate, 0.1mg/mL

TIMP1 (Marker of Lymph Node Metastasis) (2A5), CF488A conjugate, 0.1mg/mL